未登录 分享 收藏
分享 收藏
分享 收藏
分享 收藏
Survival Without Quality of Life Deterioration in the GORTEC 2014-04 OMET Randomized Phase 2 Trial in Patients with Head and Neck Cancer with Oligometastases using Stereotactic Ablative Radiation Therapy (SABR) alone or Chemotherapy and SABR 在头颈部癌寡转移患者中使用立体定向消融放射治疗（SABR）单药或化疗联合SABR的GORTEC 2014-04 OMET随机II期试验中，未发生生活质量恶化的生存情况 Thariat, Juliette; Bosset, Mathieu; Falcoz, Antoine; Vernerey, Dewi; Pointreau, Yoann; Racadot, Severine; Faivre, Jean-Christophe; Castelli, Joel; Guihard, Sebastien; Huguet, Florence; Chapet, Sophie; Tao, Yungan; Borel, Christian; Fayette, Jerome; Rambeau, Audrey; Ferrand, Francois Regis; Pechery, Adeline; Bourhis, Jean; Sun, Xu-Shan 分享 收藏
Immunoscore-IC predicts nivolumab efficacy as adjuvant treatment after salvage surgery in head and neck cancer squamous cell carcinoma: The ADJORL1 trial Immunoscore-IC预测头颈鳞状细胞癌挽救性手术后辅助治疗中使用nivolumab的疗效：ADJORL1试验 Marhic, A.; Guerlain, J.; Cozic, N.; Daste, A.; Malard, O.; Fayette, J.; Rolland, F.; Mauvais, O.; Johnson, A. C.; Salas, S.; Vinches, M.; Bozec, A.; Vergez, S.; de Mones, E.; Breuskin, I.; Iacob, M.; Archambaud, B.; Marabelle, A.; Janot, F.; Even, C. 分享 收藏
External validation of the CD8 radiomics signature as a prognostic marker in recurrent or metastatic head and neck cancer treated with nivolumab CD8影像组学特征作为接受纳武利尤单抗治疗的复发性或转移性头颈癌的预后标志物的外部验证 Adrien, L.; Even, C.; Hano, J. B.; Deny, N.; Mitrea, D.; Tao, Y.; Lefebvre, G.; Daste, A.; Saada, E. B.; Fayette, J.; Blanchard, P.; Cifliku, V.; Talebi, F.; Monard, L.; Texier, M.; Robert, C.; Classe, M.; Auperin, A.; Deutsch, E.; Sun, R. 分享 收藏
Final results of a phase II study of peltopepimut-S and cemiplimab in patients with relapsed/metastatic HPV16+oropharyngeal cancer that progressed with prior anti-PD-1 therapy 佩尔托肽-S和西米普利布在复发/转移性HPV16+口咽癌患者中的II期研究最终结果，这些患者在接受既往抗PD-1治疗后疾病进展。 Kong, A.; Even, C.; Aguilera, B.; Hesselink, M. Klein; Visscher, S.; Chung, C. H.; Park, J. C.; Adkins, D. R.; Salas, S.; Harrington, K. J.; Fayette, J.; Rottey, S.; Algazi, A.; Fury, M. G.; Melief, C. J. M.; Hooftman, L. W. 分享 收藏
HERTHENA-PanTumor01: A global phase II trial of HER3-DXd in metastatic solid tumors HERTHENA-PanTumor01：一项关于HER3-DXd在转移性实体瘤中的全球性II期临床试验 Powles, T. B.; Bhatia, A. K.; Burtness, B.; Kogawa, T.; Nishina, T.; Nakayama, I.; Fountzilas, C.; Castillo, D. R.; Mckean, M.; Meric-Bernstam, F.; Colombo, N.; Smithy, J. W.; Fayette, J.; Chandra, S.; Sternberg, D. W.; Sullivan, K. H.; Yueh, S.; Clinthorne, G.; Kudchadkar, R.; Hayashi, H. 分享 收藏
Results of the multicenter phase II FRAIL-IMMUNE trial evaluating the efficacy and safety of durvalumab (D) combined with weekly paclitaxel carboplatin in 1st-line in patients with recurrent/metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) not eligible to cisplatin 多中心II期FRAIL-IMMUNE试验结果，评估了度伐利尤单抗（D）联合每周给药的紫杉醇卡铂在一线治疗中，对于不符合顺铂使用条件的复发性/转移性头颈鳞状细胞癌（R/M SCCHN）患者的有效性与安全性。 Fayette, J.; Cropet, C.; Gautier, J.; Toullec, C.; Vinches, M.; Burgy, M.; Iacob, M.; Kaminsky-Forrett, M-C.; Salas, S.; Linot, B.; Champagnac, A.; Sondarjee, I.; Pechery, A.; Perol, D.; Bourhis, J. 分享 收藏
Petosemtamab plus pembrolizumab vs. pembrolizumab alone for first-line (1L) treatment of recurrent/metastatic (r/m) PD-L1epositive head and neck squamous cell carcinoma (HNSCC): A randomized, open-label, phase III trial Petosemtamab plus pembrolizumab与pembrolizumab单药治疗PD-L1阳性复发/转移性（r/m）头颈鳞状细胞癌（HNSCC）的一线（1L）治疗：一项随机、开放标签、III期试验 Fayette, J.; Adkins, D. R.; Psyrri, A.; Siu, L. L.; Tahara, M.; William, W. Nassib, Jr.; Pyle, R.; Shen, Y-M.; Zohren, F.; Pennella, E.; Vokes, E. E. 分享 收藏
Adapted EXTREME regimen in the first-line treatment of fit older patients with recurrent or metastatic head and neck squamous cell carcinoma (ELAN-FIT): a multicentre, singlearm, phase 2 trial Guigay, Joel; Le Caer, Herve; Ferrand, Francois-Regis; Geoffrois, Lionel; Saada-Bouzid, Esma; Fayette, Jerome; Sire, Christian; Cupissol, Didier; Blot, Emmanuel; Guillet, Pierre; Pavillet, Julien; Bozec, Laurence; Capitain, Olivier; Rolland, Frederic; Debourdeau, Philippe; Pointreau, Yoann; Falandry, Claire; Lopez, Stephane; Coutte, Alexandre; Chatellier, Thierry; Dalloz, Pierre; Ortholan, Cecile; Michel, Cecile; Lacas, Benjamin; Cheurfa, Nadir; Schwob, Dominique; Bourhis, Jean; Mertens, Cecile; Auperin, Anne 分享 收藏
IMvoke010: A phase III, double-blind randomized trial of atezolizumab (atezo) after definitive local therapy vs placebo in patients (pts) with high-risk locally advanced (LA) squamous cell carcinoma of the head and neck (SCCHN) Wong, Deborah J.; Fayette, Jerome; Teixeira, Maria; Prabhash, Kumar; Mesia, Ricard; Kawecki, Andrzej; Dechaphunkul, Arunee; Dinis, Jose; Guo, Ye; Masuda, Muneyuki; Hsieh, Ching-Yun; Ghi, Maria Grazia; Sette, Claudia Vaz de Melo; Jiang, Tao; Yan, Yibing; Kaul, Monika; Jagtiani, Ritika; Matheny, Christina; Cuchelkar, Vaikunth; Haddad, Robert 分享 收藏
Cetuximab versus methotrexate in first-line treatment of older, frail patients with inoperable recurrent or metastatic head and neck cancer (ELAN UNFIT): a randomised, open-label, phase 3trial Guigay, Joel; Ortholan, Cecile; Vansteene, Damien; Cupissol, Didier; Even, Caroline; Kaminsky, Marie -Christine; Sire, Christian; Blot, Emmanuel; Debourdeau, Philippe; Bozec, Laurence; Saada-Bouzid, Esma; Fayette, Jerome; Dalloz, Pierre; Pointreau, Yoann; Le Caer, Herve; Falandry, Claire; Digue, Laurence; Braccini, Antoine; Lopez, Stephane; Guillet, Pierre; Michel, Cecile; Cheurfa, Nadir; Schwob, Dominique; Bourhis, Jean; Mertens, Cecile; Auperin, Anne 分享 收藏
分享 收藏
Survival of bronchopulmonary cancers according to radon exposure Dessemon, Juliette; Perol, Olivia; Chauvel, Cecile; Noelle, Hugo; Coudon, Thomas; Grassot, Leny; Foray, Nicolas; Belladame, Elodie; Fayette, Jerome; Fournie, Francoise; Swalduz, Aurelie; Neidhart, Eve-Marie; Saintigny, Pierre; Tabutin, Mayeul; Boussageon, Maxime; Gomez, Frederic; Avrillon, Virginie; Perol, Maurice; Charbotel, Barbara; Fervers, Beatrice 分享 收藏
Randomized phase II study of preoperative afatinib in untreated head and neck cancers: predictive and pharmacodynamic biomarkers of activity Marret, Gregoire; Temam, Stephane; Kamal, Maud; Even, Caroline; Delord, Jean-Pierre; Hoffmann, Caroline; Dolivet, Gilles; Malard, Olivier; Fayette, Jerome; Capitain, Olivier; Vergez, Sebastien; Geoffrois, Lionel; Rolland, Frederic; Zrounba, Philippe; Laccourreye, Laurent; Saada-Bouzid, Esma; Aide, Nicolas; Benavent, Valerie; Klijianenko, Jerzy; Lamy, Constance; Girard, Elodie; Vacher, Sophie; Masliah-Planchon, Julien; de Koning, Leanne; Puard, Vincent; Borcoman, Edith; Jimenez, Marta; Bieche, Ivan; Gal, Jocelyn; Le Tourneau, Christophe 分享 收藏
Salvage chemotherapy after progression on nivolumab in patients with squamous cell carcinoma of the head and neck included in the phase II TOPNIVO trial Saleh, K.; Texier, M.; Iacob, M.; Daste, A.; Fayette, J.; Lefebvre, G.; Saada, E. B.; Zanetta, S.; Vinches, M.; Toullec, C.; Salas, S.; Kaminsky-Forrett, M-C.; Johnson, A. C.; Sire, C.; Khalife-saleh, N.; Ferrand, F. R.; Monard, L.; Auperin, A.; Even, C. 分享 收藏
Adjuvant immunotherapy after salvage surgery in head and neck cancer squamous cell carcinoma (HNSCC): Phase II trial evaluating the efficacy and the toxicity of Nivolumab (ADJORL1) Guerlain, J.; Cozic, N.; Daste, A.; Malard, O.; Fayette, J.; Rolland, F.; Mauvais, O.; Johnson, A. C.; Salas, S.; Vinches, M.; Bozec, A.; Vergez, S.; de Mones, E.; Breuskin, I.; Iacob, M.; Archambaud, B.; Janot, F.; Even, C. 分享 收藏
Nivolumab (nivo) in recurrent and/or metastatic squamous cell carcinoma of head and neck (R/M SCCHN): real-world effectiveness, quality of life (QoL) of patients and their caregivers in France (ProNiHN study) Le Tourneau, C.; Even, C.; Salas, S.; Pointreau, Y.; Ceruse, P.; Babin, E.; Fayette, J.; Rondeau, V.; Grumberg, V.; Cotte, F-E.; Govart, A.; Baumstarck, K.; Guigay, J. 分享 收藏
.png){kind=icon}
.png){kind=icon}
.png)
.png){kind=icon}
分享.png){kind=icon}
收藏.png)
ANNALS OF ONCOLOGY